Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study

BACKGROUND: Febrile neutropenia (FN) is a serious complication of myelosuppressive chemotherapy. Clinical practice guidelines recommend routine prophylactic coverage with granulocyte colony-stimulating factor (G-CSF)—such as pegfilgrastim—for most patients receiving chemotherapy with an intermediate...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Weycker, Derek, Doroff, Robin, Hanau, Ahuva, Bowers, Charles, Belani, Rajesh, Chandler, David, Lonshteyn, Alexander, Bensink, Mark, Lyman, Gary H.
Format: Artigo
Language:Inglês
Published: BioMed Central 2019
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6688232/
https://ncbi.nlm.nih.gov/pubmed/31399079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6010-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items